ASTRID

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 05 Sept 2025 filing date already counts against anyone who files later.

Record

Serial number

79434747

Mark type

Stylized text

Filed

05 Sept 2025

Published for opposition

29 Sept 2026

Attorney of record

Ashley M. Robinson

Goods and services

• Class 005 — Pharmaceuticals: Diagnostic preparations for medical purposes; diagnostic preparations and materials in the nature of diagnostic reagents, diagnostic antibody reagents or antibodies, monoclonal antibodies and buffer solutions for use in in vitro diagnostics, reagents for use in in vitro diagnostics, and medical diagnostic test strips for blood analysis, all for medical and veterinary purposes; chemical, biochemical and biological preparations, namely, chemical reagents for medical purposes, biochemical reagents for medical purposes; chemical and biochemical preparations, namely, diagnostic reagents, diagnostic antibody reagents or antibodies, monoclonal antibodies and buffer solutions for use in in vitro diagnostics, and reagents for use in in vitro diagnostics, all for veterinary purposes; biological preparations, namely, diagnostic reagents, diagnostic antibody reagents or antibodies, monoclonal antibodies and buffer solutions for use in in vitro diagnostics, and reagents for use in in vitro diagnostics, all for veterinary purposes; clinical diagnostic reagents for medical use; medical diagnostic reagents and assays for testing of body fluids; diagnostic biomarker reagents for medical or veterinary purposes; diagnostic preparations for medical purposes used by medical laboratories; medical diagnostic test strips for blood analysis; diagnostic test kits consisting primarily of diagnostic reagents, antibody reagents or antibodies, buffers, and reagents, for use in in vitro diagnostics, and test strips for blood analysis for disease testing; in vitro diagnostic agents for medical use; in-vitro diagnostics for veterinary purposes; diagnostic test kits for medical purposes consisting primarily of diagnostic reagents, antibody reagents, antibodies, buffers, and reagents, for use in in vitro diagnostics, and test strips for blood analysis disease testing; diagnostic test kits for veterinary purposes consisting primarily of diagnostic reagents, antibody reagents, antibodies, buffers, and reagents for use in in vitro diagnostics, and test strips for blood analysis for disease testing; diagnostic rapid test kits consisting primarily of diagnostic reagents, antibody reagents, antibodies, buffers, and reagents for use in in vitro diagnostics, and test strips for blood analysis for disease testing for medical purposes; diagnostic rapid test kits consisting primarily of diagnostic reagents, antibody reagents, antibodies, buffers, and reagents for use in in vitro diagnostics, and test strips for blood analysis for disease testing for veterinary purposes; medical diagnostic test kits consisting primarily of diagnostic reagents, antibody reagents, antibodies, buffers, and reagents for use in in vitro diagnostics, and test strips for detecting acute aortic syndrome; diagnostic test kits consisting primarily of diagnostic reagents, antibody reagents, antibodies, buffers, and reagents for use in in vitro diagnostics, and test strips for detecting aortic dissection; diagnostic rapid test kits consisting primarily of diagnostic reagents, antibody reagents, antibodies, buffers, and reagents for use in in vitro diagnostic apparatus, and test strips for detecting acute aortic syndrome; diagnostic rapid test kits consisting primarily of diagnostic reagents, antibody reagents, antibodies, buffers, and reagents for use in in vitro diagnostics, and test strips for detecting aortic dissection; diagnostic test kits consisting primarily of diagnostic reagents, antibody reagents or antibodies, monoclonal antibodies, buffer solutions, reagents and test strips for blood analysis, all for use in in vitro diagnostics for diagnosing the recurrence or progression of disease in patients following surgery; diagnostic test kits consisting primarily of diagnostic reagents, antibody reagents or antibodies, monoclonal antibodies, buffer solutions, reagents and test strips for blood analysis, all for use in in vitro diagnostics for diagnosing the recurrence or progression of cardiovascular disease in patients following cardiological interventions; diagnostic rapid test kits consisting primarily of diagnostic reagents, antibody reagents or antibodies, monoclonal antibodies, buffer solutions, reagents, and test strips for blood analysis, all for use in in vitro diagnostics for diagnosing the recurrence or progression of disease in patients following surgery; diagnostic rapid test kits consisting primarily of diagnostic reagents, antibody reagents or antibodies, monoclonal antibodies, buffer solutions, reagents and test strips for blood analysis, all for use in in vitro diagnostics for diagnosing the recurrence or progression of cardiovascular disease in patients following cardiological interventions and surgery.

Owner

• PeriCard Check GmbH, DE

Prosecution history

• 01 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 07 Aug 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 07 Aug 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 07 Aug 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 05 Mar 2026 — REFUSAL PROCESSED BY IB
• 18 Feb 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
• 18 Feb 2026 — REFUSAL PROCESSED BY MPU
• 24 Jan 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
• 23 Jan 2026 — NON-FINAL ACTION WRITTEN
• 21 Jan 2026 — ASSIGNED TO EXAMINER
• 16 Oct 2025 — APPLICATION FILING RECEIPT MAILED
• 16 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 16 Oct 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB